H1N flu: the destruction of the vaccine against the rest completed by late November

PARIS - Vaccines against H1N1 pandemic influenza delivered during the 2009/2010 and unused, have been destroyed by the end of November, "according to the schedule ever," said Thierry Coudert Monday, the president of the organization responsible for managing inventory.

Of the 94 million doses ordered by the government, 44 million were delivered, the health minister at the time, Roselyne Bachelot, has canceled the rest of the commands.

Nearly 6 million people have been effectively vaccinated (one or two doses). 12.6 million doses have been given to the World Health Organization and 314,000 sold in Qatar, and Monaco.

Measles epidemic mainly affects South

Measles, a disease of children? Not only. Since 2008, a terrible epidemic in Europe, an epidemic that is important not to overlook, especially in the south of France, the region most affected. The alert is twofold. It is both the Academy of Medicine and Institute of Health Surveillance (InVS).
The Academy of Medicine, said that "more than 20 000 cases were reported since 2008" in France, where 2011 was a year marked by a real outbreak. Of these 20,000 cases, "14,000 were reported between January and June 2011." For its part, the Institute of Public Health said that over the past seven months, "fifteen of the cases had a neurological complication, 639 severe pneumonia and six died."

intervenMediator: Servier would have ed to correct a Senate report

Servier Laboratories intervened in June a Senate report on the Ombudsman minimizes liability and insists that the drug agency, said on Tuesday, September 13, Le Figaro, citing excerpts from wiretaps placed on the register test. The report's author, Sen. Maria Teresa Hermange UMP, has categorically denied these claims.

Have tapped a conversation between the group's operations director Servier, Jean-Philippe Seta, and Claude Griscelli, a former member of the Council of State, Professor of Pediatrics and Genetics, former Director General of Inserm. M. Griscelli Servier leader said as speaker of the Senate Hermange, the madam, "asked to

Botulism: three victims of contaminated complain tapenade

The first three of the eight complaints from victims of contaminated tapenade made ​​by the company La Ruche in Cavaillon (Vaucluse) were recorded on the morning of Tuesday in the Superior Court of Amiens (Somme).

On the same subject

      All products of the hive bee products rappelésL'ensemble recalled

      Botulism: After "Las Delicias de Marie Claire", another brand under surveillance
      Botulism: the set of beehive products recalled

Exceeded rates of physicians: the state pushed to act

Scalded by the tax on mutual complementary health withdrew from the negotiations on the management of excess fees for physicians. The ball is in the courtyard of the executive, who wanted to solve the problem before the presidential election.Written byA few months before the presidential election, the executive hopes to get credit for a breakthrough in the delicate question of the higher fees of private practitioners. This hope was away this week, refusing to negotiate on this health issue. The Unocam, representing the families of three complementary (mutual insurance companies, pension funds) officially ended talks today. One way to protest against increasing the tax burden on them, which has been approved by Parliament.

In 2010, the French have paid out of pocket spending by 9.4% in health

Health spending in France has reached € 234.1 billion in 2010, three-quarters funded by Social Security, 13.5% of the bodies and more than 9.4% by the patients themselves.

As was the case in 2009, the unpaid portion of health spending declined slightly in 2010, according to the latest edition of "Health Accounts" published on Wednesday.

The Servier Protelos be reviewed

The risk / benefit of Protelos, an osteoporosis drug Servier, be reviewed at the Commission authorization to market Sept. 29 because of "persistent and significant, serious side effects."
129 "serious adverse events" were recorded 3.3 million cases sold from April 2009 to March 2011, according to a report presented yesterday to the Technical Committee on Pharmacovigilance (CTPV). Following this meeting, the European Agency for Health Product Safety (AFSSAPS) decided to review the Commission's benefit / risk MA on September 29, said today.